Proteome Sciences Plc Stock Performance

PMSNF Stock  USD 0.04  0.00  0.00%   
Proteome Sciences holds a performance score of 7 on a scale of zero to a hundred. The company holds a Beta of 4.26, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Proteome Sciences will likely underperform. Use Proteome Sciences jensen alpha and rate of daily change , to analyze future returns on Proteome Sciences.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Proteome Sciences plc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Proteome Sciences reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow2.2 M
Total Cashflows From Investing Activities-204 K
  

Proteome Sciences Relative Risk vs. Return Landscape

If you would invest  3.00  in Proteome Sciences plc on October 29, 2025 and sell it today you would earn a total of  1.00  from holding Proteome Sciences plc or generate 33.33% return on investment over 90 days. Proteome Sciences plc is currently producing 3.8889% returns and takes up 39.8168% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Proteome, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Proteome Sciences is expected to generate 53.31 times more return on investment than the market. However, the company is 53.31 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

Proteome Sciences Target Price Odds to finish over Current Price

The tendency of Proteome Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.04 90 days 0.04 
about 9.76
Based on a normal probability distribution, the odds of Proteome Sciences to move above the current price in 90 days from now is about 9.76 (This Proteome Sciences plc probability density function shows the probability of Proteome Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 4.26 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Proteome Sciences will likely underperform. In addition to that Proteome Sciences plc has an alpha of 3.2234, implying that it can generate a 3.22 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Proteome Sciences Price Density   
       Price  

Predictive Modules for Proteome Sciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Proteome Sciences plc. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0439.86
Details
Intrinsic
Valuation
LowRealHigh
0.000.0339.85
Details
Naive
Forecast
LowNextHigh
0.00070.0439.85
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.030.040.05
Details

Proteome Sciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Proteome Sciences is not an exception. The market had few large corrections towards the Proteome Sciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Proteome Sciences plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Proteome Sciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
3.22
β
Beta against Dow Jones4.26
σ
Overall volatility
0.01
Ir
Information ratio 0.09

Proteome Sciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Proteome Sciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Proteome Sciences plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Proteome Sciences is way too risky over 90 days horizon
Proteome Sciences has some characteristics of a very speculative penny stock
Proteome Sciences appears to be risky and price may revert if volatility continues
Proteome Sciences has high likelihood to experience some financial distress in the next 2 years
Proteome Sciences plc has accumulated 11.68 M in total debt. Proteome Sciences plc has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Proteome Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Proteome Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Proteome Sciences plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Proteome to invest in growth at high rates of return. When we think about Proteome Sciences' use of debt, we should always consider it together with cash and equity.
About 21.0% of the company outstanding shares are owned by corporate insiders

Proteome Sciences Fundamentals Growth

Proteome Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Proteome Sciences, and Proteome Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Proteome Pink Sheet performance.

About Proteome Sciences Performance

By analyzing Proteome Sciences' fundamental ratios, stakeholders can gain valuable insights into Proteome Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Proteome Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Proteome Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company was incorporated in 1993 and is based in Cobham, the United Kingdom. Proteome Sciences operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 27 people.

Things to note about Proteome Sciences plc performance evaluation

Checking the ongoing alerts about Proteome Sciences for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Proteome Sciences plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Proteome Sciences is way too risky over 90 days horizon
Proteome Sciences has some characteristics of a very speculative penny stock
Proteome Sciences appears to be risky and price may revert if volatility continues
Proteome Sciences has high likelihood to experience some financial distress in the next 2 years
Proteome Sciences plc has accumulated 11.68 M in total debt. Proteome Sciences plc has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Proteome Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Proteome Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Proteome Sciences plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Proteome to invest in growth at high rates of return. When we think about Proteome Sciences' use of debt, we should always consider it together with cash and equity.
About 21.0% of the company outstanding shares are owned by corporate insiders
Evaluating Proteome Sciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Proteome Sciences' pink sheet performance include:
  • Analyzing Proteome Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Proteome Sciences' stock is overvalued or undervalued compared to its peers.
  • Examining Proteome Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Proteome Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Proteome Sciences' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Proteome Sciences' pink sheet. These opinions can provide insight into Proteome Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Proteome Sciences' pink sheet performance is not an exact science, and many factors can impact Proteome Sciences' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Proteome Pink Sheet analysis

When running Proteome Sciences' price analysis, check to measure Proteome Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proteome Sciences is operating at the current time. Most of Proteome Sciences' value examination focuses on studying past and present price action to predict the probability of Proteome Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proteome Sciences' price. Additionally, you may evaluate how the addition of Proteome Sciences to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities